Lasmanovich Rinat, Mahmud Husny, Khaitovich Boris, Zilberman Dorit E, Rosenzweig Barak, Laufer Menachem, Portnoy Orith, Epstein Avi, Irony Avinoah, Dotan Zohar A
Department of Urology, Sheba Medical Center, Tel-Hashomer, Israel, Tel-Aviv University, Tel-Aviv, Israel.
Unit of Interventional Radiology, Sheba Medical Center, Tel-Hashomer, Israel, Tel-Aviv University, Tel-Aviv, Israel.
World J Urol. 2025 Mar 18;43(1):177. doi: 10.1007/s00345-025-05491-x.
This study aims to assess the evaluation, management, clinical outcomes and incidence of postoperative hematuria following partial nephrectomy (PNx) for renal tumors.
We retrospectively reviewed the medical charts of 936 adult patients who underwent PNx between 2008 and 2023. Patients presenting with hematuria during the first 6 months of surgery were included. Group 1, comprising patients who were treated with early angiography and selective embolization (n = 8), was compared to Group 2, patients who underwent imaging first (US or CTA), followed by angiography and selective embolization (n = 10, "delayed" angiography).
24 (2.6%) patients presented with hematuria, 18 (75%) required angiography-assisted intervention. Of those 18 patients, 17 (94.4%) were diagnosed with vascular pathologies; renal artery pseudoaneurysm (RAP) and arteriovenous fistula. Ultrasound (US) did not detect RAP in 33% of patients' initial evaluations (67% sensitivity). The median age was 67 years (IQR: 71.5-58.5 years), and the median time to hematuria was 11.5 days (IQR: 20.3- 7 days). The difference in the median interval time from presentation to embolization between Groups 1 and 2 was 20.2 h (CI 95%, p = 0.25). Group 1 had higher hemoglobin levels following therapy (p = 0.04), lower transfusion rates or antibiotic therapy (p = 0.02), shorter hospitalization stays (p = 0.03), and lower re-admission rates (p = 0.043) compared to Group 2.
RAP is ubiquitous among patients presenting with hematuria following PNx. With hematuria presentation, the use of US should be limited. For cases where selective embolization is considered, angiography is sufficient to identify vascular pathologies, guiding therapeutic intervention. Management by early angiographic intervention is associated with better clinical outcomes compared to delayed angiography following confirmatory imaging.
本研究旨在评估肾肿瘤部分肾切除术(PNx)后血尿的评估、管理、临床结局及发生率。
我们回顾性分析了2008年至2023年间接受PNx的936例成年患者的病历。纳入术后前6个月出现血尿的患者。将第1组(包括接受早期血管造影和选择性栓塞治疗的患者,n = 8)与第2组(先进行影像学检查(超声或CTA),然后进行血管造影和选择性栓塞的患者,n = 10,“延迟”血管造影)进行比较。
24例(2.6%)患者出现血尿,18例(75%)需要血管造影辅助干预。在这18例患者中,17例(94.4%)被诊断为血管病变;肾动脉假性动脉瘤(RAP)和动静脉瘘。超声(US)在33%的患者初始评估中未检测到RAP(敏感性67%)。中位年龄为67岁(四分位间距:71.5 - 58.5岁),血尿出现的中位时间为11.5天(四分位间距:20.3 - 7天)。第1组和第2组从出现症状到栓塞的中位间隔时间差异为20.2小时(95%置信区间,p = 0.25)。与第2组相比,第1组治疗后血红蛋白水平更高(p = 0.04),输血率或抗生素治疗更低(p = 0.02),住院时间更短(p = 0.03),再入院率更低(p = 0.043)。
RAP在PNx后出现血尿的患者中普遍存在。出现血尿时,超声的应用应受到限制。对于考虑选择性栓塞的病例,血管造影足以识别血管病变,指导治疗干预。与确诊成像后延迟血管造影相比,早期血管造影干预管理的临床结局更好。